Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures

• Waihay J. Wong,

  Roles Data curation, Formal analysis, Validation, Writing – original draft

  Affiliation Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Michele Baltay,

  Roles Methodology, Validation

  Affiliation Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Annaliese Getz,

  Roles Methodology, Validation

  Affiliation Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Kit Fuhrman,

  Roles Validation

  Affiliation Nanostring Technologies Inc., Seattle, Washington, United States of America

  ⨯
• Jon C. Aster,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Robert P. Hasserjian,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Olga Pozdnyakova

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: opozdnyakova@bwh.harvard.edu

  Affiliation Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  http://orcid.org/0000-0001-8376-0344

  ⨯